XR Securities’s Thermo Fisher Scientific TMO Stock Holding History

XR Securities’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,100	Closed	-$639K	–	337
2024 Q1	$639K	Sell	1,100 -3,600	-77%	-$2.02M	0.02%	182
2023 Q4	$2.49M	Buy	4,700 +1,000	+27%	+$484K	0.09%	101
2023 Q3	$1.87M	Sell	3,700 -300	-8%	-$160K	0.14%	106
2023 Q2	$2.09M	Sell	4,000 -400	-9%	-$216K	0.1%	82
2023 Q1	$2.54M	Sell	4,400 -1,600	-27%	-$902K	0.07%	86
2022 Q4	$3.3M	Buy	+6,000	New	+$3.18M	0.32%	52
2022 Q1	–	Sell	-2,900	Closed	-$341K	–	513
2021 Q4	$341K	Buy	+2,900	New	+$1.81M	0.03%	141

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

XR Securities's TMO Position: Q2 2021 in Review

XR Securities sold out of Thermo Fisher Scientific (TMO) in Q2 2021, closing a stake of 492 shares — an estimated $225K sold.

XR Securities first reported a position in TMO in Q4 2018 and held it in 5 quarters. The position peaked at $814K in Q4 2020. 2,075 funds tracked by Wall St. Rank hold TMO as of Q2 2021.

XR Securities reported no remaining Thermo Fisher Scientific position as of Q2 2021 after selling out during the quarter.
XR Securities sold 492 Thermo Fisher Scientific shares in Q2 2021, an estimated $225K.
XR Securities first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 5 quarters.
XR Securities's Thermo Fisher Scientific position peaked at $814K in Q4 2020.
2,075 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.

Based on XR Securities's 13F filing for Q2 2021, filed 26 Jul 2021.